Dr. Kirsten Kaiser

Executive Vice President Medical
& Regulatory Development

Dr. Kirsten Kaiser was appointed Executive Vice President Medicinal & Regulatory Development on 1 January 2009, having joined the Company as Vice President Clinical Research & Regulatory Affairs in January 2007. Previously, she was Vice President Plasma Integration Office & Medical Operations at ZLB Plasma Services, Vice-President Medical & Safety Operations at Aventis Bio-Services and Vice-President Worldwide Regulatory Affairs at Aventis Behring. Prior to this she held a variety of regulatory affairs and pharmacovigilance roles at Behringwerke AG earlier in her career. Dr. Kaiser holds a medical degree from Justus-Liebig University, Giessen in Germany.

Executive Management

Copyright 2012, SkyePharma. All Rights Reserved.

SkyePharma PLC is a public limited company registered in England and Wales, registration number 0107582.
Registered office: 46-48 Grosvenor Gardens, London SW1W 0EB, United Kingdom